Feedback
HIV PhenoSense GT
0092399
Ordering Recommendation

HIV-1 combined pheno- and genotyping provides antiretroviral susceptibility information for protease inhibitors (PI) and reverse transcriptase inhibitors (NRTI, NNRTI). Useful in clarifying and confirming results from HIV genotyping tests. Intended for patients with viral load >500 copies/mL.

Mnemonic
HIVPHENOGT
Methodology
Phenotyping/Genotyping
Performed
Varies
Reported
15-22 days
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Lavender (EDTA) or Plasma Preparation Tube (PPT). 
Specimen Preparation
Separate from cells within 6 hours of collection. Transfer 3 mL plasma to an ARUP Standard Transport Tube and freeze immediately. (Min: 1 mL) 
Storage/Transport Temperature
CRITICAL FROZEN. Separate specimens must be submitted when multiple tests are ordered. 
Unacceptable Conditions
Thawed specimens. 
Remarks
Provide patient's most recent viral load and viral load collection date. 
Stability
Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen at -20°C: 2 weeks; Frozen at -70°C: Indefinitely 
Reference Interval
By report
Interpretive Data


Note
Procedure should be used for patients with documented HIV-1 infection and viral loads greater than 500 copies/mL.
Hotline History
View Hotline History
CPT Code(s)
87900; 87901; 87903; 87904 x11
Components
Component Test Code*Component Chart NameLOINC
0092073Viral Load8251-1
0092074Viral Load Date19151-0
2003232EER HIV PhenoSense GT11526-1
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • HIV Resistance

Performed at Monogram Biosciences